Cooper Companies (The) (COO) : During the past 4 weeks, traders have been relatively bearish on Cooper Companies (The) (COO), hence the stock is down -3.06% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -1.11% relative to the S&P 500. The 4-week change in the price of the stock is -3.58% and the stock has fallen -0.94% in the past 1 week.
The stock has recorded a 20-day Moving Average of 2.95% and the 50-Day Moving Average is 2.09%.The 200 Day SMA reached 12.86%
Cooper Companies (The) (NYSE:COO): After opening at $177.39, the stock dipped to an intraday low of $177.04 on Friday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $180.32 and the buying power remained strong till the end. The stock closed at $179.26 for the day, a gain of 1.83% for the day session. The total traded volume was 936,797. The stocks close on the previous trading day was $179.26.
Cooper Companies (The) (COO) has been rated by 9 research analysts. Fundamentally, the highest shorterm price forecast for the stock is expected to reach $215 and the lowest price target forecast is $195. The average forecast of all the analysts is $203.89 and the expected standard deviation is $6.45.
The Cooper Companies, Inc. (Cooper), is a global medical device company. The Company operates through two business units, CooperVision, Inc. (CVI) and CooperSurgical, Inc. (CSI). CooperVision is a global manufacturer providing products for contact lens wearers. CooperSurgical focuses on supplying womens health clinicians with products and treatment options to improve the delivery of healthcare to women. CooperSurgical products fall into three main segments based on the point of healthcare delivery: Hospital, Office and Fertility Clinic. CooperVision develops, manufactures and markets a range of monthly, two-week and single-use contact lenses, featuring advanced materials and optics. CooperVision is involved in correcting vision problems such as astigmatism, presbyopia and ocular dryness, and provides innovative contact lens solutions. The CooperVision Companys brands include Biofinity, Avaira and MyDay and CooperSurgical Companys brands include Advincula Arch, SeeClear and Mobius.